News
Why is it so critical to normalise menopause in the workplace?
By Michelle Robinson Hayes, mental health trainer and preventative services lead at Vita Health Group
Responsible employers hold the power to effect real change by normalising conversations about menopause.
Although menopause is an entirely natural phase of life, women still go to great lengths to conceal their menopausal experiences and symptoms from family, friends and colleagues.
Fear of being judged, fear of being seen as incapable or incompetent, and fear that menopause and its accompanying symptoms could negatively impact their career – are just some of the reasons many women suffer in silence at work.
In fact, for some women, the mental and physical symptoms of menopause – such as hot flushes, headaches, sweating, brain fog, erratic moods and negative emotions – can be so overwhelming and distressing they feel they are left with no other option but to quit their job and leave the workplace all altogether.
A report from the Fawcett Society showed that one in 10 women who worked during the menopause has left a job due to their symptoms and a quarter of employees experiencing menopause are likely to retire early because of it.
More shocking statistics from the report show that there are 14 million working days lost in the UK to menopause a year.
The hidden cost of suppressing the dialogue around menopause
Whilst many organisations have committed time and resources to the menopause agenda in recent years, there are plenty of others who are lagging behind.
Evidently, the cost of leaving women to suffer in silence is not just borne by the women themselves, their partners and their families, it’s borne by employers and the wider society, too.
The reality is that menopausal women are the fastest-growing demographic in the workplace – according to the Faculty of Occupational Medicine, almost eight out of 10 menopausal women are in work.
And yet, even with these figures and the growing body of evidence around the benefits of supporting menopausal employees, many organisations continue to weigh up whether the menopause agenda is worth their time and resources.
In reality, companies that choose to ignore this issue not only risk alienating a crucial talent pool, they also risk falling behind industry competitors who’ve shown their hand of support.
Undeniably, the menopause will continue to impact talent retention, skills gaps and diversity for those organisations that do not respond well.
Psychological safety in the workplace has never been more important
To dispel the longstanding stigma surrounding menopause, it’s imperative organisations work to normalise conversations on the topic.
Individuals who experience the menopause should feel comfortable disclosing their challenges and seeking assistance without the fear of backlash. Whilst those supporting colleagues going through the menopause – irrelevant of age or gender – should feel confident, equipped to offer their support and able to navigate colleagues through their experience from an organisational perspective.

Michelle Robinson Hayes, mental health trainer and preventative services lead at Vita Health Group
Ensuring employees feel psychologically safe is particularly important. Why? Because every individual’s experience of menopause is unique and it would be impossible to accommodate an employee if they do not feel comfortable to share their individual needs.
Why managers play a critical role in menopause support
Managers have substantial influence over an individual’s workplace experience – new research has found that almost 70 per cent of people feel their manager has more of an impact on their mental health than their therapist or doctor.
Given this significant influence, it’s essential organisations invest in training managers – particularly those who have no experience of the menopause, and those who’ve experienced the menopause without symptoms.
Whilst some women suffer debilitating symptoms – studies show that 60-86 per cent of women experience symptoms so bothersome that they seek medical care – others may experience the menopause with no symptoms at all.
Alongside training geared toward building confidence on the topic of menopause and improving communication skills, organisations should also ensure managers understand the menopause policies and benefits available to employees so they can correctly inform their colleagues.
Talking about menopause is the beginning of positive change
Although the menopause revolution has gained momentum in recent years, the topic continues to be shrouded in secrecy across workplaces in the UK.
Research demonstrates that women in the UK take more time off during menopause compared to any other country, indicating a pressing need for change.
Menopause discrimination is deeply embedded into our society and dismantling the menopause taboo won’t occur overnight.
Nonetheless, responsible employers hold the power to effect real change by normalising conversations about menopause and ensuring employees have access to necessary support and training.
If you’re contemplating when the right time is to cultivate a menopause-friendly workplace, recognise that the time is now.
Michelle Robinson Hayes is a mental health trainer and preventative services lead at Vita Health Group. She is a leading expert in workplace mental health and is passionate about helping employees overcome their mental health challenges.
Events
Research project of the year: What the judges want to see
Submitting your research project for Femtech World Awards recognition can feel daunting.
What makes one project stand out from another?
After reviewing successful submissions from previous years, we’ve identified the key elements that transform good research into award-winning work.
Innovation That Solves Real Problems
Judges aren’t just looking for novelty – they’re looking for innovation that addresses genuine gaps in women’s health.
The best submissions clearly articulate a specific problem and demonstrate how their research offers a fresh approach to solving it.
Ask yourself: Does your research tackle an underserved area? Are you approaching a known problem from a new angle?
The most compelling projects often focus on issues that have been overlooked, understudied or inadequately addressed by existing solutions.
Whether you’re investigating menopause in the workplace, developing better diagnostic tools for endometriosis, or exploring mental health interventions for new mothers, clarity about the problem you’re solving is essential.
Rigorous Methodology
Strong research stands on solid foundations. Judges carefully evaluate your methodology to ensure your findings are credible and reproducible.
This doesn’t mean your research needs to be complete – early-stage projects are welcome – but you should demonstrate thoughtful research design.
Include details about your sample size, data collection methods, controls, and analytical approaches.
If you’re conducting qualitative research, explain how you’re ensuring validity. If you’re building a technological solution, describe your testing protocols.
Transparency about limitations shows intellectual honesty and strengthens rather than weakens your submission.
Measurable Impact Potential
The research projects that win hearts and awards are those with clear pathways to real-world impact.
Judges want to see beyond the research itself to understand how your work will improve women’s lives.
Consider questions like: Who will benefit from this research? How many people could be affected? What would successful implementation look like?
Whether your impact is clinical, social, economic, or policy-related, be specific.
Instead of saying “this will help women,” try “this diagnostic tool could reduce endometriosis diagnosis time from 7-10 years to under 2 years for an estimated 200 million women worldwide.”
Inclusivity and Diversity Considerations
Award-winning FemTech research recognises that women are not a monolith.
Judges increasingly value projects that consider diversity across age, race, ethnicity, socioeconomic status, disability, and geographic location.
Have you thought about how your research applies across different populations? Are you inadvertently excluding certain groups?
The strongest submissions acknowledge these considerations and, where possible, design research to be inclusive or clearly define the specific population being served.
Clear Communication
Even groundbreaking research won’t win if judges can’t understand it. The ability to communicate complex ideas clearly is crucial.
Avoid unnecessary jargon, define technical terms, and structure your submission logically.
Think of your submission as telling a story: Here’s the problem, here’s why it matters, here’s what we did, here’s what we found, and here’s why it matters for the future.
Feasibility and Sustainability
Judges appreciate ambitious research, but they also value realistic plans.
Show that you’ve thought about practical considerations: Do you have the resources to complete this work? Is your timeline reasonable?
For projects seeking commercialisation, is there a viable path to market?
Demonstrating that you’ve considered challenges and have strategies to overcome them shows maturity and increases confidence in your project’s success.
Your Passion Matters
Finally, don’t underestimate the power of genuine passion.
The researchers who win aren’t just technically proficient – they deeply care about their work and its potential to create change.
Let that commitment shine through in your submission.
Ready to submit? Find out more about the awards and enter for free here.
Insight
Topical HRT protects bone density in women with period loss – study
Transdermal HRT best protects bone density in women with functional hypothalamic amenorrhoea, a condition that stops periods, a review of trials has found.
The meta-analysis pooled randomised clinical trials involving 692 participants and found transdermal hormone replacement therapy and teriparatide increased bone mineral density by between 2 and 13 per cent.
Functional hypothalamic amenorrhoea can follow anorexia or intense exercise. Bone mineral density measures bone strength and the amount of mineral in bone.
Around half of women with the condition have low bone mineral density, compared with about 1 per cent of healthy women, and their fracture risk is up to seven times higher.
The research was conducted by scientists at Imperial College London and Imperial College Healthcare NHS Trust.
Professor Alexander Comninos, senior author of the study and consultant endocrinologist at the trust, said: “Bone density is lost very rapidly in FHA and so addressing bone health early is very important to reduce the lifelong risk of fractures.
“Our study provides much needed comparisons of all the available treatments from all available studies.
“Clearly the best treatment is to restore normal menstrual cycles and therefore oestrogen levels through various psychological, nutritional or exercise interventions – but that is not always possible.
“The foundation for bone health is good calcium and vitamin D intake (through diet and/or supplements) but we have additional treatments that are more effective.”
When FHA is diagnosed, clinicians first try to restore periods through lifestyle measures, including psychological and dietary support, but these can fail. Guidelines then recommend giving oestrogen, though the best form was unclear.
The team reviewed all prior randomised trials comparing therapies, including oral and transdermal oestrogen, and also assessed teriparatide, a prescription bone-building drug used for severe osteoporosis.
They found no significant benefit for oral contraceptive pills or oral hormone therapy.
A recent UK audit reported that about a quarter of women with anorexia-related FHA are prescribed the oral contraceptive pill for bone loss; the study suggests using transdermal therapy instead.
Comninos said: “Our goal is simple: to help women receive the right treatment sooner and to protect their bone health in the long-term.
“We hope this study provides clinicians with better evidence to choose transdermal oestrogen when prescribing oestrogen and so inform future practice guidelines.
“Right now, millions of women with FHA may not be receiving the best treatments for their bone health.”
Insight
AI cuts interval breast cancers in Swedish trial
-
Insight4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Features4 weeks agoBest menopause apps and products for 2026
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Entrepreneur4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Fertility3 weeks agoChina’s birth rate hits record low despite government fertility efforts







1 Comment